Literature DB >> 9315309

RNA and protein requirements for eukaryotic selenoprotein synthesis.

M J Berry1, G W Martin, S C Low.   

Abstract

Selenium has been recognized as an essential nutrient in animals since the 1950s. Demonstration of the role of dietary selenium in protection from oxidative stress followed in the early 1970s, and was largely attributed to its presence as an integral part of cellular glutathione peroxidase. However, the functions of this enzyme did not explain many of the other effects of selenium deficiency. The identification of other mammalian selenoproteins during the last few years has provided new insights into the functions of this trace nutrient. The discovery that type 1 deiodinase (D1) is a selenoenzyme, in addition to unveiling an essential role for selenium in thyroid hormone action, has had more far-reaching implications. Studies of this protein opened the door for investigation of the requirements for eukaryotic selenoprotein synthesis, and the features that distinguish this pathway from the corresponding prokaryotic pathway. Selenium is present in a number of prokaryotic and eukaryotic proteins in the form of the unusual amino acid, selenocysteine. Incorporation of selenocysteine into these proteins requires a novel translation step in which UGA specifies selenocysteine insertion. Since UGA codons are typically recognized as translation stop signals, an intriguing question is raised: How does a cell recognize and distinguish a UGA selenocysteine codon from a UGA stop codon? In this review, we will focus on what is known about selenocysteine incorporation in eukaryotes, briefly summarizing initial studies and discussing a few recent advances in our understanding of this unique "recoding" process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315309

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  4 in total

1.  Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer's disease.

Authors:  Dae Y Hwang; Jung S Cho; Jae H Oh; Sun B Shim; Seung W Jee; Su H Lee; Su J Seo; Sang-Koo Lee; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element.

Authors:  Konstantin V Korotkov; Sergey V Novoselov; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  A highly efficient form of the selenocysteine insertion sequence element in protozoan parasites and its use in mammalian cells.

Authors:  Sergey V Novoselov; Alexey V Lobanov; Deame Hua; Marina V Kasaikina; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

4.  The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

Authors:  Antonietta Santoro; Elena Ciaglia; Vanessa Nicolin; Alessandra Pescatore; Lucia Prota; Mario Capunzo; Matilde V Ursini; Stefania L Nori; Maurizio Bifulco
Journal:  Inflamm Res       Date:  2017-12-11       Impact factor: 4.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.